Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UPC | US
0.06
1.82%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
23/04/2026
3.36
3.30
3.36
3.20
Universe Pharmaceuticals INC a pharmaceutical company engages in the development manufacturing marketing distribution and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers including biomedical drugs medical instruments traditional Chinese medicine pieces products and dietary supplements. Its customers include pharmaceutical companies hospitals clinics and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.1%1 month
98.9%3 months
89.7%6 months
102.7%-
-
0.36
0.24
0.13
0.31
0.18
-
-4.92M
79.45M
79.45M
-
-13.51
-82.00
-30.20
-50.22
0.09
1.89
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.54
Range1M
1.31
Range3M
2.95
Rel. volume
0.61
Price X volume
11.28K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 3.9 | 54.97M | 27.87% | n/a | 81.86% |
| Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.21 | 53.52M | -4.98% | n/a | 0.50% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.899 | 41.14M | 10.99% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.05 | 39.75M | 1.94% | n/a | 25.73% |
| Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 9.37 | 26.74M | -8.23% | n/a | -104.44% |
| India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3397 | 25.69M | -3.22% | n/a | 4.33% |
| Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0501 | 21.04M | -6.70% | n/a | 0.00% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 2.35 | 12.57M | -2.89% | n/a | 0.00% |
| China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 2.1214 | 7.37M | 2.98% | n/a | 19.00% |
| Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 1.03 | 5.71M | -2.83% | n/a | 13.20% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 3.66 | 66.10M | -8.03% | n/a | 5.48% |
| Unifi Inc | UFI | Textile Manufacturing | 3.55 | 64.81M | -1.66% | n/a | 52.56% |
| Culp Inc | CULP | Textile Manufacturing | 3.04 | 37.97M | 1.00% | n/a | 11.29% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5899 | 11.40M | 3.13% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.52 | 7.60M | -24.64% | 0.03 | 16.03% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.355 | 5.46M | -1.39% | n/a | 422.08% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3768 | 3.52M | 0.65% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.1963 | 1.87M | -6.12% | n/a | 19.98% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0088 | 811.49K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.36 | 749.36K | -2.16% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.31 | 24.85 | Cheaper |
| Ent. to Revenue | 0.18 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.36 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 89.67 | 65.24 | Riskier |
| Debt to Equity | 0.24 | -1.88 | Expensive |
| Debt to Assets | 0.13 | 0.48 | Cheaper |
| Market Cap | 79.45M | 3.71B | Emerging |